UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007547
Receipt No. R000008900
Scientific Title Multicenter randomized phase ll study of XELOX plus bevacizumab or XELIRI plusbevacizumab as first-line chemotherapy for metastatic or recurrent colorectal cancer
Date of disclosure of the study information 2012/03/22
Last modified on 2016/11/16 09:01:49

No. Disposal Last modified on Item of update
1 Insert 2012/03/21 20:16:48
2 Update 2016/06/29 20:23:12 UMIN ID1
3 Update 2016/11/16 08:59:50 Email
Email
Name of person sending information
Name of person sending information
Email
Name of primary sponsor
Organization
4 Update 2016/11/16 09:01:29 Control
Key inclusion criteria
5 Update 2016/11/16 09:01:49 Recruitment status


Contact us.